Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Just grab another 5K
View:
Post by Actuarial on Mar 04, 2021 9:58am

Just grab another 5K

before more positive NRs looming, such as end of Ph2 meeting with FDA, start of Ph3, fast track 352, IND 340, uplisting Naz, etc. Anything below $6 is bargain as it will soon be a solid bottom. GLTA longs!
Comment by WalkOverTheStrt on Mar 04, 2021 10:46am
Might be a bargain but as long as we are on CA exchange this stock is going to langush IMO. Need USA institions to wade in / list on NASDAQ. Dan and mgmt can state they are under valued all they want but we aren't in the right market to get noticed / or bought... tired of bs CA exchange, more games than even the US...
Comment by Actuarial on Mar 04, 2021 11:35am
I wouldn't worry too much about that. ATE has more than C$70M cash in bank. And therefore, as long as the science is solid, it is a sure bet to winning big. And, uplisting to Naz is something good to have but not something must to have - no need for funding, no necessary for PP/dilution. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities